Voluntary Nature Of Adverse Event Reporting Is Flaw In System - Kennedy

One of the main criticisms that can be leveled against FDA's Medwatch program is that it is a voluntary system, Senate Health Committee Ranking Minority Member Kennedy (D-Mass.) said Feb. 24 at a Drug Information Association meeting in Washington, D.C.